Showing results (2031-2040 of 2,140) with videos related to

Sort By:
Pageof 214
Journal of Neurosurgery. Spine|September 24, 2022
Prospective, randomized controlled multicenter study of posterior lumbar facet arthroplasty for the treatment of spondylolisthesisDomagoj Coric, Ahmad Nassr, Paul K Kim, et al.
Spine|December 27, 2023
Gender and Sex Differences in Health-related Quality of Life, Clinical Outcomes and Survival after Treatment of Metastatic Spine DiseaseC Rory Goodwin, Meghan Price, Andrea N Goodwin, et al.
Elife|March 15, 2022
The repurposing of Tebipenem pivoxil as alternative therapy for severe gastrointestinal infections caused by extensively drug-resistant Shigella sppElena Fernández Álvaro, Phat Voong Vinh, Cristina de Cozar, et al.
Transfusion|February 7, 2017
Blood Group Antigen Matching Influence on Gestational Outcomes (AMIGO) studyMeghan Delaney, Agneta Wikman, Leo van de Watering, et al.
Spine|April 15, 2024
Postoperative C5 Palsy after Anterior or Posterior Decompression for Degenerative Cervical Myelopathy: A Subgroup Analysis of the Multicenter, Prospective, Randomized, Phase III, CSM-Protect Clinical TrialAlex B Bak, Ali Moghaddamjou, Mohammed Alvi, et al.
ACS Infectious Diseases|March 19, 2021
Repurposing Infectious Disease Hits as Anti-Cryptosporidium LeadsMatthew A Hulverson, Ryan Choi, Molly C McCloskey, et al.
Biorxiv : the Preprint Server for Biology|February 7, 2023
Loss of the endocytic tumor suppressor HD-PTP phenocopies LKB1 and promotes RAS-driven oncogenesisChang-Soo Seong, Chunzi Huang, Austin C Boese, et al.
The Journal of Infectious Diseases|March 23, 2017
Bumped-Kinase Inhibitors for Cryptosporidiosis TherapyMatthew A Hulverson, Sumiti Vinayak, Ryan Choi, et al.
Plos Neglected Tropical Diseases|July 30, 2025
Anti-Cryptosporidium efficacy of BKI-1708, an inhibitor of Cryptosporidium calcium-dependent protein kinase 1Ryan Choi, Matthew A Hulverson, Deborah A Schaefer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2024
A Phase I First-in-Human Study of ABBV-011, a Seizure-Related Homolog Protein 6-Targeting Antibody-Drug Conjugate, in Patients with Small Cell Lung CancerDaniel Morgensztern, Neal Ready, Melissa L Johnson, et al.
Pageof 214